ROMATOLOJİK HASTALIKLARDA KOGNİTİF DİSFONKSİYONLAR

Abstract

Romatizmal hastalığı olan bireylerin yüzde 90'ından fazlasında dikkat ve hafıza problemleri görülmektedir. Kronik inflamasyon merkezi sinir sisteminde nöroinflamatuar strese yol açarak, günlük kognisyonla ilişkili aktivitelerin tamamlanmasında ek kortikal kaynakların kullanılmasına neden olabilir. Ayrıca, beyin bölgelerinin, ağrı ile olan meşguliyetleri nedeniyle kognitif görevlerini yerine getiremediklerinden dolayı kognitif disfonksiyon meydana gelebilir. Romatizmal hastalıklarda bilişsel bozulmaya katkıda bulunan faktörler hastalık türüne bağlı olabilir. Romatoid Artrit’li çoğu hasta, inflamasyon arttıkça izole kognitif görevleri sağlıklı bireylerle aynı düzeyde gerçekleştirebilmek için, daha fazla serebral korteks bölgesi kullanmaktadır. Lupus’ta kognitif disfonksiyonun altında yatan yollar hala araştırılmaktadır ve parametreler henüz tam olarak doğrulanıp geniş çapta kabul edilmemiştir. Sistemik Skleroz’lu hastalarda soğuğa maruz kalmanın zihinsel veya bilişsel etkilerine ilişkin çeşitli raporlar mevcuttur. Primer Sjögren Sendromu’nda sınırlı kanıtlar hipoperfüzyonun kognitif işlev bozukluğuyla ilişkili olabileceğini göstermektedir. Fibromiyalji’de ğrı derecesinin kognitif disfonksiyon düzeyi ile direk ilişkili olduğu ortak görüştür. Primer Sistemik Vaskülitler’de serebral hipoperfüzyon nedeniyle kognitif etkilenim olabilir. Behçet hastalığında kognitif disfonksiyon yaş, anksiyete-depresif bozukluklar, kronik stres etkenleri ve minör beyin multifokal subkortikal parankimal MRG lezyonları ile ilişkilidirler. Bazı faktörlerin kognitif disfonksiyona neden olduğu bulunmuştur. Ancak belirtiler arasında ayrım yapma konusunda özgüllükleri zayıftır, bu durum klinik kullanımı sınırlamaktadır (kafa karıştırıcı faktörlerin varlığı ve güvenilir biyobelirteçlerin eksikliği).

Keywords

• Romatolojik Hastalık
• Kognitif Disfonksiyon
• Ağrı

COGNITIVE DYSFUNCTIONS IN RHEUMATOLOGICAL DISEASES

Abstract

More than 90% of individuals with rheumatic diseases experience attention and memory problems. Chronic inflammation can lead to neuroinflammatory stress in the central nervous system, causing the use of additional cortical resources to complete activities related to daily cognition. Moreover, cognitive dysfunction may occur because brain regions cannot perform cognitive tasks due to their preoccupation with pain. Factors contributing to cognitive impairment in rheumatic diseases may depend on the type of disease. Most patients with Rheumatoid Arthritis use more cerebral cortex areas to perform isolated cognitive tasks at the same level as healthy individuals as inflammation increases. The pathways underlying cognitive dysfunction in Lupus are still being investigated, and the parameters have not yet been fully validated and widely accepted. In patients with Systemic Sclerosis, there are various reports on the mental or cognitive effects of exposure to cold. Limited evidence in Primary Sjogren's Syndrome suggests that hypoperfusion may be associated with cognitive dysfunction. In Fibromyalgia, it is a common view that the degree of pain is directly related to the level of cognitive dysfunction. In Primary Systemic Vasculitides, cognitive effects may occur due to cerebral hypoperfusion. In Behçet's disease, cognitive dysfunction is associated with age, anxiety-depressive disorders, chronic stress factors, and minor brain multifocal subcortical parenchymal MRI lesions. Some factors have been found to cause cognitive dysfunction. However, their specificity in distinguishing between symptoms is weak, limiting clinical use (due to the presence of confounding factors and the lack of reliable biomarkers).

Keywords

• Rheumatic Disease
• Cognitive Dysfunction
• Pain

References

1. Roebuck-Spencer TM, Yarboro C, Nowak M, Takada K, Jacobs G, Lapteva L, et. al. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 2006;55:434 – 441.
2. Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG. A rating scale for fi bromyalgia and chronic fatigue syndrome (the Fibro Fatigue scale) . Journal of Psychosomatic Research. 2002;52:501 – 509
3. Berryman C, Stanton TR, Bowering KJ, Tabor A, McFarlane A, Moseley GL. Do people with chronic pain have impaired executive function? A meta-analytical review. Clin Psychol Rev. 2014;34 (7):563–579
4. Bjekic J, Zivanovic M, Puric D, Oosterman JM, Filipovic SR. Pain and executive functions: a unique relationship between Stroop task and experimentally induced pain. Psychol Res. 2018; 82 (3):580–589.
5. Mo J, Park, J, Oh H. Correlates of Cognitive Impairment of Rheumatic Disease: Systematic Review and Meta-analysis. J Korean Acad Nurs. 2016;46(1):1-18
6. Oláh C, Schwartz N, Denton C, Kardos Z, Putterman C, Szekanecz Z. Cognitive dysfunction in autoimmune rheumatic diseases. Arthritis Res Ther. 2020; 22(1): 78.
7. Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et. al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68(6):954–60.
8. Carli L, Tani C, Vagnani S, Signorini V, Mosca M. Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact–A systematic literature review. Semin Arthritis Rheum. 2015;45(2):190– 4.

9. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56
10. Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14:217–31.
11. Schrepf A, Kaplan CM, Ichesco E, Larkin T, Harte SE, Harris RE, et. al. A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. Nat Commun. 2018;9(1): 2243.
12. Kaplan C, Minc A, Basu N, Schrepf A. Inflammation and the Central Nervous System in Inflammatory Rheumatic Disease. Current Rheumatology Reports. (2019) 21: 67.
13. Nahin RL, DeKosky ST. Comorbid pain and cognitive impairment in a nationally representative adult population: prevalence and associations with health status, health care utilization, and satisfaction with care. Clin J Pain. 2020;36(10):725–739.
14. Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci USA. 2023; 120(9):e2215192120
15. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinicalresearch. Prog Neurobiol. 2011; 93(3):385–404.
16. Oosterman JM, Derksen LC, van Wijck AJ, Kessels RP, Veldhuijzen DS. Executive and attentional functions in chronic pain: does performance decrease with increasing task load? Pain Res Manag. 2012; 17(3):159–165.
17. Glass JM, Williams DA, Fernandez-Sanchez ML, Kairys A, Barjola P, Heitzeg MM, et. al. Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia. J Pain. 2011; 12 (12): 1219–1229.
18. Yang S, Chang MC. (Chronic pain: structural and functional changes in brain structures and associated negative affective states. Int J Mol Sci. 2019; 20(13):3130.
19. Meade T, Manolios N, Cumming SR, Conaghan PG, Katz P. Cognitive impairment in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2018;70(1):39–52.
20. Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6(2):164– 73.
21. Bell T, Trost Z, Buelow MT, Clay O, Younger J, Moore D, et. al., Meta-analysis of cognitive performance in fibromyalgia. J Clin Exp Neuropsychol. 2018; 40(7): 698–714.
22. Li T, Zhou L, Zhao H, et al. Fatigue in ankylosing spondylitis is associated with psychological factors and brain gray matter. Front Med (Lausanne). 2019; 6:271.
23. Vitturi BK, Suriano ES, Pereira de Sousa AB, Torigoe DY. Cognitive impairment in patients with ankylosing spondylitis. Can J Neurol Sci. 2020;47:219–225.
24. Garcia LOKL, Suehiro ATS Jr, Dos Santos Gomez DC, Yoshikawa GSS, Kamikoga CK, Vitturi BK. Cognitive impairment in patients with psoriatic arthritis. Acta Neurol Belg. 2022; 122:91–96
25. Sunkureddi P, Doogan S, Heid J, et al. Evaluation of selfreported patient experiences: insights from digital patient communities in psoriatic arthritis. J Rheumatol. 2018; 45:638–647.
26. Sunkureddi P, Gibson D, Doogan S, Heid J, Benosman S, Park Y. Using self-reported patient experiences to understand patient burden: learnings from digital patient communities in ankylosing spondylitis. Adv Ther. 2018; 35:424–437
27. Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, et al. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int. 2023;43(1):89-97.
28. Rayes HA, Tani C, Kwan A, Marzouk S, Colosimo K, Medina-Rosas J, et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(2):240–55
29. Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, et. al. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis. 2013;72(Suppl 2):ii76–9.
30. Kello N, Anderson E, Diamond B. Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials. Arthritis Rheumatol. 2019;71(9):1413-1425.
31. Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(3):137–52.
32. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, et. al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074–82.
33. Mizrachi M, Anderson E, Carroll KR, Tehrani N, Volpe BT, Diamond B. Cognitive dysfunction in SLE: An understudied clinical manifestation. J Autoimmun. 2022;132:102911.
34. Mackay M, Vo A, Tang CC, Small M, Anderson EW, Ploran EJ, et. al. Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment. JCI insight. 2019;4(1).
35. Mouthon L, Alami S, Boisard AS, Chaigne B, Hachulla E, Poiraudeau S. Patients' views and needs about systemic sclerosis and its management: a qualitative interview study. BMC Musculoskelet Disord. 2017;18(1):230.
36. Khedr EM, El Fetoh NA, Gamal RM, Elzohri MH, Azoz NMA, Furst DE. Evaluation of cognitive function in systemic sclerosis patients: a pilot study. Clin Rheumatol. 2020;39(5):1551-1559.
37. Giuliodori G, Fraticelli P, Bartolini M, Cagnetti C, Baruffaldi R, Rocchi MBL, et. al. Cognitive and cerebral hemodynamic impairment in scleroderma patients. Eur J Neurol. 2009;16(12):1285-90.
38. Le Guern V, Belin C, Henegar C, Moroni C, Maillet D, Lacau C, et al. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjögren syndrome: a case-control study. Ann Rheum Dis. 2010;69(1):132–137.
39. Manzo C, Martinez-Suarez E, Kechida M, Isetta M, Serra-Mestres J. Cognitive Function in Primary Sjogren's Syndrome: A Systematic Review. Brain Sci. 2019;9(4):85.
40. Goulabchand R, Castille E, Navucet S, Etchecopar-Etchart D, Matos A, Maria A, et. al. The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patients. Sci Rep. 2022;12(1):13176.
41. Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A, Fusaro E et al. Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res. 2015; 67(1): 143–150.
42. Rutledge DN, Mouttapa M, Wood PB. Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res. 2009; 58 (5): 359–367
43. Montoro CI, Duschek S, de Guevara Munoz-Ladron C, Fernandez-Serrano MJ, Reyes Del Paso GA. Aberrant cerebral blood flow responses during cognition: implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology. 2014; 29 (2): 173–182.
44. Seo J, Kim SH, Kim YT, Song HJ, Lee JJ, Han SW, et al. Working memory impairment in fibromyalgia patients associated with altered frontoparietal memory network. PLoS One. 2012; 7(6): e37808
45. Ceko M, Bushnell MC, Fitzcharles MA, Schweinhardt P. Fibromyalgia interacts with age to change the brain. Neuroimage Clin. 2013; 3: 249–260.
46. Robinson ME, Craggs JG, Price DD, Perlstein WM, Staud R. Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain. 2011; 12 (4): 436–443.
47. Di Comite G, Sabbadini MG. Neurological involvement in rheumatological diseases. Neurol Sci. 2005;26 Suppl 1:S9-14.
48. Mullin E, Aristotelidou V, Blackburn D, Jenkins T, Hadjivassiliou M. Cognitive deficits in vasculitis of the nervous system: a cross-sectional study. Postgrad Med. 2019;131(7):546-549.
49. Ovcharov PS, Lisitsyna TA, Veltishchev DY, Burenchev DV, Ishchenko DA, Seravina OF, et. al. Cognitive disorders in Behçet's disease. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2):11-17.
50. Urbain F, Hardy-Léger I, Adebs-Nasser G, de Menthon M, Pivert C, Mausoléo A, et. al. Psychiatric Symptoms and Cognitive Disorders in Behçet's Disease: A Single-Center, Cross-Sectional Study. J Clin Med. 2023;12(9):3149.
51. Tay SH, Fairhurst A-M, Mak A. Clinical utility of circulating anti-N-methyl-D-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren's syndrome: an updated meta-analysis. Autoimmun Rev. 2017; 16(2):114–122.
52. Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci. 2009; 29(44):13746–13750.
53. Harrison MJ, Morris KA, Horton R, Toglia J, Barsky J, Chait S, et al. Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology. 2005;65:1325–7
54. Shen B, Li Y, Du X, Chen H, Xu Y, Li H, et al. Effects of cognitive behavioral therapy for patients with rheumatoid arthritis: a systematic review and metaanalysis. Psychol Health Med. 2020;25:1179–91
55. Ding Z, Leung PY, Lee TL, Chan AS. Effectiveness of lifestyle medicine on cognitive functions in mild cognitive impairments and dementia: A systematic review on randomized controlled trials. Ageing Res Rev. 2023;86:101886.